SEMTECH CORP (SMTC)
SEMTECH CORP (SMTC)
| Cash Flow | 2026-04-26 | 2026-01-25 | 2025-10-26 | 2025-07-27 |
|---|---|---|---|---|
| Net income | 26,563 | -29,795 | -2,862 | -27,064 |
| Depreciation and amortization | 9,161 | 10,174 | 10,129 | 10,314 |
| Amortization of right-of-use assets | 1,574 | 1,428 | 1,392 | 1,356 |
| Right-of-use asset impairment | NaN | 0 | NaN | NaN |
| Investment impairments and credit loss reserves, net | NaN | 10,387 | 0 | 0 |
| Impairment of goodwill | NaN | 42,794 | 0 | 41,991 |
| Intangible impairment | NaN | 1,777 | NaN | NaN |
| Accretion of deferred financing costs | 1,090 | 1,091 | 1,172 | 1,271 |
| Write-off of deferred financing costs | -1,617 | NaN | 2,923 | 364 |
| Write-off of deferred financing cost and debt discount | NaN | 2,388 | NaN | NaN |
| Loss on extinguishment of debt | NaN | 0 | 0 | 0 |
| Induced conversion expense | NaN | 0 | 21,188 | NaN |
| Interest rate swap termination | 0 | 0 | 416 | 743 |
| Deferred income taxes | -1,844 | -91 | -2,935 | -2,437 |
| Share-based compensation | 26,446 | 16,453 | 17,138 | 17,297 |
| Loss on disposition of business operations and assets | -8 | -34 | 1 | -16 |
| Equity method income | 1,621 | -364 | 16 | -62 |
| Gain from sale of investments | 100 | 0 | 0 | 0 |
| Corporate-owned life insurance, net | -2,393 | -708 | -820 | -734 |
| Amortization of inventory step-up | NaN | 0 | NaN | NaN |
| Accounts receivable, net | 14,055 | -5,442 | 11,317 | -12,325 |
| Inventories | 7,180 | 8,575 | 2,449 | 13,001 |
| Other assets | 3,155 | 6,485 | 2,778 | 5,051 |
| Accounts payable | 8,044 | 6,889 | 4,416 | 1,420 |
| Accrued liabilities | -13,681 | 10,411 | 6,040 | 4,004 |
| Other liabilities | -1,148 | -1,701 | 199 | -3,337 |
| Net cash provided by operating activities | 36,183 | 61,487 | 47,462 | 44,395 |
| Proceeds from sales of property, plant and equipment | 42 | 5 | 0 | 3 |
| Purchase of property, plant and equipment | 8,172 | 2,430 | 2,819 | 2,884 |
| Proceeds from sale of investments | 100 | 0 | 1,400 | 0 |
| Purchase of investments | NaN | 0 | 0 | 0 |
| Purchase of intangibles | 5,274 | 608 | 2,635 | 2,250 |
| Acquisition, net of cash acquired | 29,188 | 21,472 | NaN | NaN |
| Proceeds from corporate-owned life insurance | NaN | 0 | 0 | 0 |
| Premiums paid for corporate-owned life insurance | 0 | 0 | 0 | 0 |
| Net cash used in investing activities | -42,492 | -24,505 | -4,054 | -5,131 |
| Proceeds from revolving line of credit | 50,000 | 0 | NaN | NaN |
| Payments of revolving line of credit | 50,000 | 0 | 0 | NaN |
| Payments of term loans | 0 | 0 | 171,212 | NaN |
| Proceeds from convertible senior notes | NaN | 0 | 402,500 | NaN |
| Payments of convertible senior notes | NaN | 0 | 280,950 | NaN |
| Repurchase of warrants | NaN | 0 | 217,761 | NaN |
| Proceeds from unwind of convertible note hedge | NaN | 0 | 242,251 | NaN |
| Purchase of capped calls | NaN | 0 | 31,395 | NaN |
| Payments of term loans | NaN | NaN | NaN | 35,000 |
| Proceeds from issuance of common stock, net of issuance costs | NaN | 0 | NaN | NaN |
| Proceeds from interest rate swap termination | NaN | 0 | 58 | 237 |
| Deferred financing costs | 0 | 1,027 | 10,062 | 72 |
| Payments for employee share-based compensation payroll taxes | 26,585 | 8,549 | 6,553 | 3,290 |
| Proceeds from exercise of stock options | 787 | 2,612 | 1,038 | 468 |
| Distributions to noncontrolling interest | NaN | 0 | 0 | 0 |
| Net cash used in financing activities | -25,798 | -6,964 | -47,086 | -27,657 |
| Effect of foreign exchange rate changes on cash and cash equivalents | 238 | 491 | -212 | 479 |
| Net (decrease) increase in cash and cash equivalents | -31,869 | 30,509 | -3,890 | 12,086 |
| Cash and cash equivalents at beginning of period | 195,179 | 164,670 | 168,560 | 156,474 |
| Cash and cash equivalents at end of period | 163,310 | 195,179 | 164,670 | 168,560 |